The Irish Times

Ryanair buyback lifts stock almost 1%

S&P 500 index closes up on $25bn sale of Forest Laboratories to Actavis

Wed Feb 19 2014 - 01:00

Chief executive Brent Saunders insists the move would not be only for tax reasons

Mon Dec 23 2013 - 19:47

The chief executive of Royalty Pharma is still keen to talk to Ireland’s largest indigenous pharma group about making a deal work

Fri Jun 21 2013 - 01:00